The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,196,765 in first-year total cost, median $722,761.
Most frequent study sections
- Clinical Neuroscience and Neurodegeneration Study Section[CNN]2
- Special Emphasis Panel[ZRG1 PSE-C (51)]1
Most frequent institutions
- BRIGHAM AND WOMEN'S HOSPITAL1
- STANFORD UNIVERSITY1
- UNIVERSITY OF PENNSYLVANIA1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2019 | The impact of early Tau pathology on cognitive progression and neuropsychiatric symptoms in Parkinson's disease1R01NS115114-01 | ANDREASSON, KATRIN I.POSTON, KATHLEEN LOMBARD | STANFORD UNIVERSITY, CA | $781,525 | CNN |
| 2019 | Biomarkers of cognitive decline in Parkinson's Disease1R01NS115139-01 | CHEN-PLOTKIN, ALICE S | UNIVERSITY OF PENNSYLVANIA, PA | $722,761 | CNN |
| 2019 | Genome-wide Prediction of Dementia in Parkinson Disease1R01NS115144-01 | SCHERZER, CLEMENS R | BRIGHAM AND WOMEN'S HOSPITAL, MA | $692,479 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.